Chengdu Shiji Biopharmaceutical Co., Ltd. announced that it will receive CNY 60,000,000 in its equity round of funding on August 2, 2023. The transaction includes participation from existing investors, from Liaoning Chengda Biotechnology Co.,Ltd. for CNY 18,000,000 and to retain its 30% stake and Infund Holding Co., Ltd. for CNY 42,000,000 and 70% stake in the company. The transaction has been reviewed and approved at the third meeting of the fifth board of directors held by the investor and does not need to be submitted to the company's shareholders' meeting.